MAGLE
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Magle Chemoswed is founded on strategic acquisitions aimed at driving growth and diversifying risk. The Group includes three operational areas. Magle Chemoswed, a contract development and manufacturing organization (CDMO). Magle PharmaCept, an established sales and marketing company for the development and direct sales of the Groups medical technology products, and Magle Biopolymers A/S, a specialized manufacturing organization of Dextran technology.
Read moreRevenue M
EBIT-% (adj.)
EPS (adj.)
Dividend %
Interim report Q3'26
Extraordinary general meeting '26
Delisting '26
Don't miss out - create an account and get all the possible benefits